Literature DB >> 22305452

Pituitary incidentaloma.

Israel B Orija1, Robert J Weil, Amir H Hamrahian.   

Abstract

Pituitary incidentalomas (PIs) are commonly encountered in clinical practice. While most are microincidentalomas (<1 cm) and not functional, in some cases their identification may lead to discovery of unrecognized abnormalities such as pituitary hormonal deficiencies, excess hormone secretion or visual field defects. Although the majority are pituitary adenomas, the potential list of differential diagnosis is extensive. A limited biochemical work up for asymptomatic patients with microincidentalomas, to include measurement of prolactin and IGF-1, is reasonable, with further studies to be tailored based on the clinical picture. All patients with macroincidentalomas (≥1 cm) should be evaluated for hypopituitarism and undergo visual field testing if the sellar mass abuts or compresses the optic chiasm. Most PIs can be followed, closely without surgery over time, but some may require surgical removal, especially if they are found to be macroincidentalomas at presentation, encroaching on or abutting the optic chiasm, or are found to be functional, excluding prolactinomas. Recovery of pituitary function may be seen in some patients with mass effect following resection of a sellar mass. The association of headache and pituitary incidentalomas remains a diagnostic challenge. There are no randomized controlled studies to guide the follow up approach when surgery is not indicated; most of the follow up algorithms in the literature are based on personal experience. Most retrospective series on natural history indicate that microincidentalomas tend not to grow; without a need for long-term follow up unless the patient becomes symptomatic. Macroincidentalomas, on the other hand, have a propensity to grow and need a more aggressive follow up approach to minimize morbidity.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22305452     DOI: 10.1016/j.beem.2011.07.003

Source DB:  PubMed          Journal:  Best Pract Res Clin Endocrinol Metab        ISSN: 1521-690X            Impact factor:   4.690


  8 in total

Review 1.  A 68-year-old man with an incidentally discovered pituitary lesion.

Authors:  Omar Saeed; Manoela Braga
Journal:  CMAJ       Date:  2017-04-24       Impact factor: 8.262

Review 2.  Management of nonfunctioning pituitary adenomas (NFAs): observation.

Authors:  Wenyu Huang; Mark E Molitch
Journal:  Pituitary       Date:  2018-04       Impact factor: 4.107

3.  Retrospective observational analysis of non-irradiated non-functioning pituitary adenomas.

Authors:  I Karamouzis; R Berardelli; N Prencipe; A Berton; C Bona; G Stura; M Corsico; V Gasco; M Maccario; E Ghigo; S Grottoli
Journal:  J Endocrinol Invest       Date:  2015-07-28       Impact factor: 4.256

4.  ACTH-secreting pituitary microadenomas are associated with a higher prevalence of central hypothyroidism compared to other microadenoma types.

Authors:  Nestoras Mathioudakis; Sritika Thapa; Gary S Wand; Roberto Salvatori
Journal:  Clin Endocrinol (Oxf)       Date:  2012-12       Impact factor: 3.478

5.  Is pituitary MRI screening necessary in cluster headache?

Authors:  Lou Grangeon; Emer O'Connor; Daisuke Danno; Thanh Mai Pham Ngoc; Sanjay Cheema; Erling Tronvik; Indran Davagnanam; Manjit Matharu
Journal:  Cephalalgia       Date:  2021-01-06       Impact factor: 6.292

6.  Infundibulo-hypophysitis-like radiological image in a patient with pituitary infiltration of a diffuse large B-cell non-Hodgkin lymphoma.

Authors:  A León-Suárez; P Roldán-Sarmiento; M A Gómez-Sámano; A Nava-De la Vega; V M Enríquez-Estrada; F J Gómez-Pérez; D Cuevas-Ramos
Journal:  Endocrinol Diabetes Metab Case Rep       Date:  2016-12-17

7.  Growth Pattern and Prognostic Factors of Untreated Nonfunctioning Pituitary Adenomas.

Authors:  Kihwan Hwang; Taehun Kwon; Jay Park; Jin-Deok Joo; Jung Ho Han; Chang Wan Oh; Chae-Yong Kim
Journal:  J Korean Neurosurg Soc       Date:  2019-02-27

8.  A comparative, population-based analysis of pituitary incidentalomas vs clinically manifesting sellar masses.

Authors:  Nadine M Vaninetti; David B Clarke; Deborah A Zwicker; Churn-Ern Yip; Barna Tugwell; Steve Doucette; Chris Theriault; Khaled Aldahmani; Syed Ali Imran
Journal:  Endocr Connect       Date:  2018-04-30       Impact factor: 3.335

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.